Trupanion (NASDAQ:TRUP) PT Lowered to $34.00

Trupanion (NASDAQ:TRUP) had its price target cut by Canaccord Genuity Group from $40.00 to $34.00 in a report published on Friday morning, Benzinga reports. They currently have a buy rating on the financial services provider’s stock.

Several other research analysts also recently weighed in on TRUP. Stifel Nicolaus boosted their price target on Trupanion from $25.00 to $28.00 and gave the company a hold rating in a report on Friday, February 16th. Evercore ISI decreased their price target on Trupanion from $35.00 to $31.00 and set an outperform rating on the stock in a research note on Tuesday, February 20th. Finally, Piper Sandler cut their price objective on shares of Trupanion from $28.00 to $22.00 and set a neutral rating on the stock in a report on Friday. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of Hold and a consensus target price of $32.33.

Trupanion Price Performance

Trupanion stock traded down $3.93 during midday trading on Friday, reaching $19.85. 2,330,524 shares of the company were exchanged, compared to its average volume of 553,707. The firm’s 50-day simple moving average is $25.67 and its 200-day simple moving average is $26.77. Trupanion has a 1 year low of $18.45 and a 1 year high of $36.82. The company has a market capitalization of $833.50 million, a price-to-earnings ratio of -31.02 and a beta of 1.76. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.02. The company had revenue of $306.12 million for the quarter, compared to analysts’ expectations of $300.51 million. Trupanion had a negative net margin of 2.31% and a negative return on equity of 9.10%. The firm’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period last year, the company earned ($0.60) EPS. On average, analysts anticipate that Trupanion will post -0.43 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TRUP. SG Americas Securities LLC purchased a new position in Trupanion in the third quarter valued at about $261,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Trupanion by 35.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,011 shares of the financial services provider’s stock worth $254,000 after buying an additional 2,367 shares during the last quarter. BluePath Capital Management LLC acquired a new stake in Trupanion in the third quarter valued at $31,000. Nisa Investment Advisors LLC boosted its stake in Trupanion by 108.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 18,930 shares of the financial services provider’s stock valued at $534,000 after acquiring an additional 9,869 shares during the last quarter. Finally, Check Capital Management Inc. CA grew its holdings in Trupanion by 32.1% during the 3rd quarter. Check Capital Management Inc. CA now owns 22,925 shares of the financial services provider’s stock worth $646,000 after acquiring an additional 5,575 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.